These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer. Liu B, Su F, Li Y, Qi X, Liu X, Liang W, You K, Zhang Y, Zhang J. Biomed Pharmacother; 2017 Apr; 88():911-917. PubMed ID: 28178621 [Abstract] [Full Text] [Related]
3. MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer. Raychaudhuri M, Bronger H, Buchner T, Kiechle M, Weichert W, Avril S. Breast Cancer Res Treat; 2017 Apr; 162(3):511-521. PubMed ID: 28181130 [Abstract] [Full Text] [Related]
5. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients. Kassem NM, Makar WS, Kassem HA, Talima S, Tarek M, Hesham H, El-Desouky MA. Asian Pac J Cancer Prev; 2019 Sep 01; 20(9):2749-2755. PubMed ID: 31554373 [Abstract] [Full Text] [Related]
8. Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment. Al-Khanbashi M, Caramuta S, Alajmi AM, Al-Haddabi I, Al-Riyami M, Lui WO, Al-Moundhri MS. PLoS One; 2016 Sep 01; 11(4):e0152032. PubMed ID: 27064979 [Abstract] [Full Text] [Related]
12. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy. Luengo-Gil G, García-Martínez E, Chaves-Benito A, Conesa-Zamora P, Navarro-Manzano E, González-Billalabeitia E, García-Garre E, Martínez-Carrasco A, Vicente V, Ayala de la Peña F. Cell Oncol (Dordr); 2019 Oct 01; 42(5):627-644. PubMed ID: 31115881 [Abstract] [Full Text] [Related]
14. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients. Yadav P, Mirza M, Nandi K, Jain SK, Kaza RC, Khurana N, Ray PC, Saxena A. Tumour Biol; 2016 Nov 01; 37(11):15275-15282. PubMed ID: 27696295 [Abstract] [Full Text] [Related]
16. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy]. Litviakov NV, Garbukov EIu, Slonimskaia EM, Tsyganov MM, Denisov EV, Vtorushin SV, Khristenko KIu, Zav'ialova MV, Cherdyntseva NV. Vopr Onkol; 2013 Nov 01; 59(3):334-40. PubMed ID: 23909034 [Abstract] [Full Text] [Related]
17. Prognostic Significance of Serum miR-22, miR-125b, and miR-15b in Non-Small Cell Lung Cancer Patients. Shi GL, Zhang XY, Chen Y, Ma S, Bai WQ, Yin YJ. Clin Lab; 2020 Jun 01; 66(6):. PubMed ID: 32538046 [Abstract] [Full Text] [Related]
18. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer. Wang YJ, Huang XY, Mo M, Li JW, Jia XQ, Shao ZM, Shen ZZ, Wu J, Liu GY. Asian Pac J Cancer Prev; 2015 Jun 01; 16(11):4603-8. PubMed ID: 26107211 [Abstract] [Full Text] [Related]